BDBM191763 US10669227, Compound Curcumin::US11608309, Compound Curcumin::US9187397, 1::US9187406, Curcumin::curcumin
SMILES COc1cc(\C=C\C(=O)CC(=O)\C=C\c2ccc(O)c(CO)c2)ccc1O
InChI Key InChIKey=UAVJPMNEDOIHEI-YPCIICBESA-N
Data 13 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 13 hits for monomerid = 191763
Affinity DataIC50: 8.20E+3nMAssay Description:The NF-kB activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cel...More data for this Ligand-Target Pair
TargetNeutrophil collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 1.40E+4nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 2.90E+4nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 8.50E+4nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
TargetCollagenase 3(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 1.10E+5nMT: 2°CAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
TargetNeutrophil collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 1.40E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
TargetCollagenase 3(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 1.10E+5nMAssay Description:Table 10: The efficacy of MMP-2 inhibition was as follows: compound 6>compound 7>compound 8. Although compound 6 showed similar efficacy as curcumin ...More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 8.50E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
TargetCollagenase 3(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 1.10E+5nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair
TargetNeutrophil collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 1.40E+4nMAssay Description:Table 1 shows the IC50 of curcumin, compound 1, and compound 2, compared to a standard Zn++ binding & MMPI (matrix metalloproteinase inhibitor), 1,10...More data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 2.90E+4nMAssay Description:Table 1 shows the IC50 of curcumin, compound 1, and compound 2, compared to a standard Zn++ binding & MMPI (matrix metalloproteinase inhibitor), 1,10...More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 8.50E+4nMAssay Description:Table 10: The efficacy of MMP-2 inhibition was as follows: compound 6>compound 7>compound 8. Although compound 6 showed similar efficacy as curcumin ...More data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
The Research Foundation of State University of New York
US Patent
The Research Foundation of State University of New York
US Patent
Affinity DataIC50: 2.90E+4nMAssay Description:It has been observed that 50 and 100 μM concentrations of curcumin decreased TNFα production by endotoxin-stimulated human monocytes (HMs) ...More data for this Ligand-Target Pair